Table 2—

Characteristics of patients at baseline and after DHEA treatment (n = 10) or placebo administration (n = 10)

DHEA (50 mg/dl)
Placebo
Baseline12 weeksBaseline12 weeks
Age (years)63.9 ± 11.158.0 ± 16.77
BMI (kg/m2)25.7 ± 1.125.4 ± 1.425.7 ± 1.525.1 ± 1.4
Systolic blood pressure (mmHg)127.7 ± 4.6127.7 ± 3.0137.0 ± 2.8132.0 ± 2.7
Plasma glucose (mmol/l)7.32 ± 0.377.40 ± 0.526.63 ± 0.816.36 ± 0.71
Creatinine (μmol/l)78.7 ± 3.884.9 ± 5.981.3 ± 3.582.2 ± 2.9
LDL cholesterol (mmol/l)3.00 ± 0.223.17 ± 0.273.82 ± 0.143.53 ± 0.31
A1C (%)6.5 ± 0.26.8 ± 0.36.4 ± 0.56.7 ± 0.6
HOMA index11.8 ± 1.912.7 ± 2.212.4 ± 2.011.3 ± 2.8
  • Data are means ± SE.